Experimental Setup and Design.

A) Schematic of experimental urodynamic recordings in anesthetized rats. Volume of voided urine was also collected. B) Experimental timeline of studies. Animals received a unilateral T9 contusion, and urodynamic recordings were conducted at 5 days post contusion. During the recording, a baseline was established for urodynamic output. Animals received vehicle HPCD, and consecutive doses of ampakines CX1739 at doses of 5 mg/kg, 10 mg/kg, and 15 mg/kg. Each drug dose was spaced apart by 45 mins.

Histological assessment of T9 Contusion (T9Ct) injury epicenter.

Serial, transverse sections (20 μm thickness) spanning ∼1 cm around the lesion epicenter (T9-T10) were stained with Cresyl violet in order to identify the extent of injury. A representative image from an intact (left) and T9 contused (right) spinal cord. Scale bar, 300 μm.

Impact of T9 contusion on cystometric bladder function and EUS EMG activity.

A) Example bladder pressure and EUS EMG trace of coordinated voiding in intact animals (left column) and in SCI rats, five days following spinal cord injury (right column). Expanded traces show EUS EMG activity. Note different y-scales in expanded trace used for clarity. (B-E) Summary of the impact of T9 contusion injury on various cystometric outcomes. Baseline pressure was reduced in the SCI group as compared to intact animals. Injured rats had significantly higher threshold pressures, voided volume, and intercontraction intervals. B) Baseline pressure (cmH2O); C) Threshold pressure (cmH2O); D) Voided volume (μl); E) Intercontraction interval (s). F-I) Summary of the impact of T9 contusion injury on EUS EMG activity. Injured rats had a significantly higher duration, area under the curve, and RMSpeak EMG. F) Threshold (cmH2O); G) Duration (s); H) area under the curve (arbitrary unit, a.u.); I) RMSpeak EMG (a.u.). *p < 0.05. Data are presented as bar plots with all individual data points corresponding to individual animal means. Group means are shown in diamond with error bars depicting ± SE.

Impact of ampakine treatment on cystometric bladder function.

A) Example trace of bladder cystometry in intact animals (left column) and in SCI rats five days following spinal cord injury (right column) following HPCD or ampakine infusion (5 mg/kg, 10 mg/kg, 15 mg/kg). (B-E) Summary of the impact of ampakine treatment on cystometric outcomes in intact (n=8) and SCI (n=7) rats. Ampakine treatment significantly reduced the intercontraction interval, voided volume, and threshold pressure in injured rats. HPCD did not alter cystometry parameters compared to baseline. Ampakine treatment caused a decrease in threshold and peak pressure but did not affect intercontraction interval or voided volume in intact rats. B) Intercontraction interval (s); C) Peak pressure (cmH2O); D) Voided volume (μl); E) Threshold pressure (cmH2O). Data are presented as line plots with all individual data points corresponding to an individual animal means. Group means are represented with a diamond and error bars depict ± SE.

Mean data of cystometry measures at 5-days post-injury following HPCD or ampakine CX1739 treatment. Intact (n = 8), SCI (n = 7) groups. Data are presented as Mean ± SD.

Statistical post-hoc comparisons for cystometric outcomes with significant treatment and group interactions in spontaneously voiding intact (n=8) and SCI (n=7) rats following ampakine treatment.

Impact of ampakine treatment on EUS EMG activity.

A-B) Example bladder pressure trace, raw EUS EMG trace (blue), and RMS EUS EMG (orange) activity during spontaneous voiding in intact animals and in SCI rats five days following spinal cord injury following HPCD or ampakine infusion (5 mg/kg, 10 mg/kg, 15 mg/kg). Note the re-emergence of coordinated EUS EMG activity following 15 mg/kg ampakine treatment in injured rats (black arrow). (C-F) Summary of the impact of ampakine treatment on EUS EMG activity in intact (n=8) and SCI (n=7) rats. Ampakine treatment reduced the threshold pressure in intact and SCI rats. HPCD had no impact on any outcomes. C) Duration (s); D) Threshold (cmH2O; defined as the bladder pressure at which EUS EMG burst was evoked (intersection of red dotted lines)); E) area under the curve (arbitrary unit, a.u.); F) RMSpeak EMG (a.u.). Data are presented as line plots with all individual data points corresponding to individual animal means. Group means are represented by a diamond, with error bars depicting ± SE.

Mean data of EUS EMG activity at 5-days post-injury following HPCD or ampakine CX1739 treatment. Intact (n = 8), SCI (n = 7) groups. Data are presented as Mean ± SD.

Ampakine rescue coordinated voiding in non-voiding rats following SCI.

(A) Example bladder pressure and EUS EMG trace of non-coordinated voiding five days following spinal cord injury (Baseline). Black arrows indicate manual expression/emptying of the bladder. The second trace (Post-Ampakine) indicates the same rat following 10 mg/kg CX1739 with voiding re-established. Expanded EUS EMG trace in middle panels shows a lack of coordinated bursting during baseline recording of SCI rats (i). Following ampakine treatment, coordinated EUS bursting is restored (grey arrows; ii). (B-F) Summary of the impact of 10 mg/kg ampakine treatment on cystometry and EUS EMG outcomes in SCI rats displaying non-coordinated voiding (n=3). Ampakine treatment reduced non-voiding and partial voiding contractions in all three rats and established coordinated voiding. No rat exhibited coordinated EUS bursting during the voiding phase at baseline. Ampakine treatment re-established coordinated EUS bursting in all three rats. B. Non-voiding contractions; C) Complete voiding contractions; D) Non-complete voiding contractions; E) RMSpeak EMG; F) EUS EMG Bursting Events. Data are presented as individual data points corresponding to individual animal means.